Clinical Trials Directory

Trials / Completed

CompletedNCT04731168

Prevention of Sleep Apnea After General Anaesthesia With a MAD

Prevention of Sleep Apnea After General Anaesthesia With a Mandibular Advancement Device: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Centre Hospitalier Universitaire Vaudois · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sleep apneic episodes increase after general anaesthesia up to the third postoperative night. A mandibular advancement device, called MAD, is a small device that is inserted in the patient's mouth during the night and allows the advancement of the mandible, preventing sleep apneic episodes. The objective of this randomized controlled trial is to determine whether a MAD reduces the impact of general anaesthesia on the increase of the sleep apneic episodes in the postoperative period. All patients will have their sleep-related respiratory data measured using a portable respiratory polygraphy recorder (ResMed Embletta® system). This portable recorder allows a non-invasive recording of nasal airflow through a nasal cannula, oxygen saturation (SpO2) via finger pulse oximetry, respiratory efforts through thoracic and abdominal belts, and body position.

Conditions

Interventions

TypeNameDescription
DEVICEMandibular advancement devicePatients will have a mandibular advancement device during the first postoperative night

Timeline

Start date
2021-02-01
Primary completion
2023-10-31
Completion
2023-10-31
First posted
2021-01-29
Last updated
2023-11-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04731168. Inclusion in this directory is not an endorsement.